Press Release
'Zydus receives Tentative Approval from the USFDA for Fingolimod Capsules'.14-07-2017
14-07-2017
'Some gaps in the emerging markets portfolio, but not very significant'
Pankaj R Patel is passing on the baton of Zydus Cadila to his 38-year-old son Sharvil Patel14-07-2017
Statement Of Complaints As On 30.06.2017.
In compliance with the provisions of Regulation 13 (3) of the SEBI Regulations 2015, the status of complaints are attached.13-07-2017
Pankaj Patel steps down as Cadila MD, son to take over
Board of Directors of Cadila Healthcare has unanimously approved the appointment of Sharvil P Patel13-07-2017
Shareholding for the Period Ended June 30, 2017
Cadila Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here12-07-2017
Press Release
Zydus receives final approval from the USFDA for Memantine Hydrochloride tablets.12-07-2017
Cadila Healthcare in a long-term uptrend
Investors with a long-term perspective can buy the stock in declines09-07-2017
Zydus starts drug trial for anaemia
Cadila Healthcare Ltd (Zydus Cadila), on Wednesday, announced commencement of a Phase-II trial investigating Zyani1, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), as a...05-07-2017